NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30/09/2024
Voltar para busca
Dado oficial do USPTO
FLUOTAG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
30/09/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5
Data de depósito
15/03/2017
Data de registro
10/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/09/2024
Última transação
30/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Goettingen, DE
Examinador
LOTT, MAUREEN DALL
Localização atual
Historical data usage
Descrição da marca
The mark consists of the literal element "FluoTag" in stylized letters, with "F" and "T" capitalized.
Titulares e representantes
Titulares
NanoTag Biotechnologies GmbH
Representantes
Ryan D. Artis RIVERSIDE LAW LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical reagents for scientific or industrial purposes and not for medical or veterinary usechemical reagents containing antibodies or proteins having antibody-like properties; Chemical reagents for scientific or industrial purposes and not for medical or veterinary usefor microscopyflow cytometrywestern blotimagingfluorescence based analysistissue analysis; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents containing antibodies or proteins having antibody-like properties; Diagnostic or analytical kits other than for medical or veterinary use containing chemical reagents for microscopyflow cytometrywestern blotimagingfluorescence based analysistissue analysis
Classe 5
Pharmaceutical and veterinary preparations containing antibodiesall for use in treating cancer; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing antibodiesall for use in treating inflammatory diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating cancer; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating autoimmune diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating infectious diseases; Pharmaceutical and veterinary preparations containing proteins having antibody-like propertiesall for use in treating inflammatory diseases; Diagnostic preparations for medical or veterinary purposesnamely preparations containing antibodies or proteins having antibody-like properties ; Drugs being pharmaceutical preparations containing antibodiesall for use in treating cancer; Drugs being pharmaceutical preparations containing antibodiesall for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing antibodiesall for use in treating infectious diseases; Drugs being pharmaceutical preparations containing antibodiesall for use in treating inflammatory diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating cancer; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating autoimmune diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating infectious diseases; Drugs being pharmaceutical preparations containing proteins having antibody-like propertiesall for use in treating inflammatory diseases; Vaccines containing antibodies; Vaccines containing proteins having antibody-like properties
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/09/2024
E815
TEAS SECTION 8 & 15 RECEIVED
22/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/01/2018
PUBO
PUBLISHED FOR OPPOSITION
23/01/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/06/2017
GNRT
NON-FINAL ACTION E-MAILED
09/06/2017
CNRT
NON-FINAL ACTION WRITTEN
09/06/2017
DOCK
ASSIGNED TO EXAMINER
08/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/03/2017
NWAP
NEW APPLICATION ENTERED
18/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FLUOTAG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.